Global Nucleic Acid Isolation and Purification Market By Type (KITS, REAGENTS, and INSTRUMENTS), By Application (Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Hospitals and Diagnostic Centers), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028
- Published date: Aug 2022
- Report ID: 40243
- Number of Pages: 361
- Format:
- keyboard_arrow_up
- 1. Nucleic Acid Isolation and Purification Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Nucleic Acid Isolation and Purification Market Overview
- 3.1. Nucleic Acid Isolation and Purification Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Production Analysis by Region/Company
- 3.9. Industry chain Analysis
- 3.10. Marketing Strategy
- 3.1. Nucleic Acid Isolation and Purification Market Dynamics
- 4. Global Nucleic Acid Isolation and Purification Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Nucleic Acid Isolation and Purification Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. KITS
- 4.4. REAGENTS
- 4.5. INSTRUMENTS
- 5. Global Nucleic Acid Isolation and Purification Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Nucleic Acid Isolation and Purification Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Academic and Government Research Institutes
- 5.4. Pharmaceutical and Biotechnology Companies
- 5.5. Contract Research Organizations
- 5.6. Hospitals and Diagnostic Centers
- 6. Global Nucleic Acid Isolation and Purification Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.2.1. Europe
- 6.2.1. Europe Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Spain
- 6.2.1.7. Rest of Europe
- 6.2.1. Europe Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia-Pacific
- 6.3.1. Asia-Pacific Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Nucleic Acid Isolation and Purification Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Nucleic Acid Isolation and Purification Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Shanghai Kehua
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. Agilent Technologies
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. Bio-Rad Laboratories
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Danaher Corporation
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. F HOFFMAN-LA ROCHE AG
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. General Electric
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. General Electric
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. Promega
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. Qiagen NV
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 7.12. Sigma-Aaldrich
- 7.12.1. Company Overview
- 7.12.2. Financial Highlights
- 7.12.3. Product Portfolio
- 7.12.4. SWOT Analysis
- 7.12.5. Key Strategies and Developments
- 7.13. TAKARA BIO
- 7.13.1. Company Overview
- 7.13.2. Financial Highlights
- 7.13.3. Product Portfolio
- 7.13.4. SWOT Analysis
- 7.13.5. Key Strategies and Developments
- 7.14. Thermo Fisher Scientific
- 7.14.1. Company Overview
- 7.14.2. Financial Highlights
- 7.14.3. Product Portfolio
- 7.14.4. SWOT Analysis
- 7.14.5. Key Strategies and Developments
- 7.15. Beijing BioTeke
- 7.15.1. Company Overview
- 7.15.2. Financial Highlights
- 7.15.3. Product Portfolio
- 7.15.4. SWOT Analysis
- 7.15.5. Key Strategies and Developments
- 7.16. Beijing BoAo
- 7.16.1. Company Overview
- 7.16.2. Financial Highlights
- 7.16.3. Product Portfolio
- 7.16.4. SWOT Analysis
- 7.16.5. Key Strategies and Developments
- 7.17. Beijing Tianwei
- 7.17.1. Company Overview
- 7.17.2. Financial Highlights
- 7.17.3. Product Portfolio
- 7.17.4. SWOT Analysis
- 7.17.5. Key Strategies and Developments
- 7.18. Invitrogen
- 7.18.1. Company Overview
- 7.18.2. Financial Highlights
- 7.18.3. Product Portfolio
- 7.18.4. SWOT Analysis
- 7.18.5. Key Strategies and Developments
- 7.19. Whatman
- 7.19.1. Company Overview
- 7.19.2. Financial Highlights
- 7.19.3. Product Portfolio
- 7.19.4. SWOT Analysis
- 7.19.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Nucleic Acid Isolation and Purification Market Introduction
- Shanghai Kehua
- Agilent Technologies Inc. Company Profile
- Bio-Rad Laboratories, Inc. Company Profile
- Danaher Corporation Company Profile
- F HOFFMAN-LA ROCHE AG
- General Electric
- Promega
- QIAGEN NV Company Profile
- Sigma-Aaldrich
- Takara Holdings Inc. (Takara Bio USA, Inc.) Company Profile
- Thermo Fisher Scientific Company Profile
- Beijing BioTeke
- Beijing BoAo
- Beijing Tianwei
- Invitrogen
- Whatman
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |